Atakan YILMAZ, Üzeyir ÇİMEN, Canan ULUOĞLU, Yeşim KINACI ÇİMEN, Alten OSKAY, Murat SEYİT, Mert ÖZEN, İbrahim TÜRKÇÜER, Gizem ONCEL YEL, Mehmet ULUTÜRK, Aykut KEMANCI

Factors Affecting Admission Frequency and Compliance with Antihypertensive Treatment of Patients Presenting to the Emergency Department with Hypertensive Attack

Aim: Admission to the emergency department (ED) due to a hypertensive attack (HTA) is common. Our study explores patients’ compliance with HTA to blood pressure (BP) treatment, the interrelationship of BP values, and their interaction with other factors. Material and Method: Two hundred and sixty seven patients admitted to our ED with the complaint of HTA and previously diagnosed with hypertension were enrolled in this study. During the data collection phase of the study, the Hill-Bone Compliance to High Blood Pressure Therapy Scale (HBCS) and a questionnaire including the sociodemographic characteristics, hypertension-related status, and dietary habits were filled in through face-to-face interviews with the patients. Results: The patients’ mean systolic blood pressure (SBP) was 168.77±26.83, and their mean diastolic blood pressure (DBP) was 98.03±10.44 at the time of admission. Their mean HBCS score turned out to be 4.78±1.79. The mean HBCS total scores tended to decrease significantly as the level of education increased. The patients restricting their salt intake and going on a diet achieved lower HBCS scores, and the difference between the groups was significant. When the patients’ mean SBP and DBP were compared with their HBCS scores, a moderately low correlation was noted between the mean HBCS scores and the mean SBP. Conclusion: The patients with an educational status at the primary school level and below presented lower compliance with treatment. When the HBCS scores were compared in terms of whether the patients went on a diet or not, the mean scores of the dieters turned out to be lower. The patients with high compliance with treatment presented lower SBP and DBP.

Keywords:

compliance with treatment, hypertensive attack, lifestyle change,

PDF

___

1. Torrellas C, Carril JC, Torrellas RC. Benefits of Pharmacogenetics in the Management of Hypertension. J Pharmacogenomics Pharmacoproteomics. 2014;5(2):1. doi:10.4172/2153-0645.1000126.
2. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, High Blood Pressure Clinical Practice Guideline. Hypertension. 2018;71(6):1269–1324. doi:10.1161/HYP.0000000000000066.
3. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al; List of authors/Task Force members:. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2018;36(12):2284–2309. doi:10.1097/ HJH.0000000000001961.
4. Xie X, Atkins E, Lv J, Bennett A, Neal B, Ninomiya T, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and metaanalysis. Lancet. 2016; 387(10017), 435-443. doi:10.1016/ S0140-6736(15)00805-3.
5. Kaplan NM, Lieberman E. Clinical Hypertension. 7th ed. Williams & Wilkins, Baltimore;1998:34-38.
6. Forman JP. Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women. JAMA. 2009;302(4):401411. doi:10.1001/jama.2009.1060.
7. Sonne-Holm, S, Sørensen TI, Jensen, G, Schnohr P. Independent effects of weight change and attained body weight on prevalence of arterial hypertension in obese and non-obese men. BMJ (Clinical research ed.). 1989;299(6702):767–770. doi:10.1136/bmj.299.6702.767.
8. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361(9369):1629–1641. doi:10.1016/S0140-6736(03)13302-8.
9. Wang, NY, Young JH, Meoni LA, Ford DE, Erlinger TP, Klag MJ. Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins Precursors Study. Archives of internal medicine. 2008;168(6):643–648. doi:10.1001/archinte.168.6.643.
10. Carson AP, Howard G, Burke G, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middleaged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57(6):1101–1107. doi:10.1161/ HYPERTENSION AHA.110.168005.
11. Ferreira I, Peeters LL, Stehouwer, CD. Preeclampsia and increased blood pressure in the offspring: meta-analysis and critical review of the evidence. Journal of hypertension. 2009;27(10) ;19551959. doi:10.1097/HJH.0b013e328331b8c6.
12. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. American Heart Association Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47(2):296308. doi:10.1161/01.HYP.0000202568.01167.B6.
13. Brook RD, Appel LJ, Rubenfire M, Ogedegbe G, Bisognano JD, Elliott WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the american heart association. Hypertension. 2013;61(6):1360–1383. doi:10.1161/ HYP.0b013e318293645f.
14. James PA, Oparil, S, Carter BL, Cushman WC, DennisonHimmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5):507–520. doi:10.1001/jama.2013.284427.
15. Gün Y, Korkmaz M. Hipertansif Hastaların Tedavi Uyumu ve Yaşam Kalitesi. Dergipark Dergisi. 2014;7(2):98–108.
16. Öngen Z. Çözümü Zor Bir Toplumsal Sorun: Hipertansiyon. Klinik Gelişim. 2005;18(2):4–7.
17. Kim MT, Hill MN, Bone LR, Levine DM. Development and Testing of The Hill‐Bone Compliance to High Blood Pressure Therapy Scale. Progress in Cardiovascular Nursing. 2000;15(3):90–96. 36. doi:10.1111/j.1751-7117.2000. tb00211.x.
18. Karademir M, Köseoğlu IH, Vatansever K, Van Den Akker M. Validity and Reliability of The Turkish Version of The Hill-Bone Compliance to High Blood Pressure Therapy Scale for Use in Primary Health Care Settings. The European Journal of General Practice. 2009;15(4):207–211. doi:10.3109/13814780903452150.
18. Altun B, Arıcı M, Nergizoğlu G, Derici Ü, Karatan O, Turgan Ç, et al. Prevalence, Awareness, Treatment and Control of Hypertension in Turkey (The PatenT Study) in 2003. Journal of Hypertension. 2005;23(10):1817–1823. doi:10.1097/01. hjh.0000176789.89505.59.
19. İçyeroğlu G. Hipertansiyon Hastalarının Tedaviye Uyumu ve Yaşam Kalitesi. Elazığ: Fırat Üniversitesi. 2012; 24.
20. Şahin NŞ. Hipertansiyon Yönetiminde Hasta Uyumu ve Hastaların Sağlık Anlayışlarına Yönelik Bir Girişimin Uyum Üzerine Etkisi. Aile Hekimliği Uzmanlık Tezi. Adnan Menderes Üniversitesi Tıp Fakültesi, Aydın. 2014;25.
21. Vatansever Ö, Ünsar S. Esansiyel Hipertansiyonlu Hastaların İlaç Tedavisine Uyum/Öz Etkililik Düzeylerinin ve Etkileyen Faktörlerin Belirlenmesi. Turk Soc Cardiol Turkish Journal of Cardiovascular Nursing. 2014;5(8):66–74. doi:10.17049/ ataunihem.527473.
22. Alhaddad IA, Hamoui O, Hammoudeh A, Mallat S. Treatment Adherence and Quality of Life in Patients on Antihypertensive Medications in a Middle Eastern Population: Adherence. Vasc Health Risk Manag. 2016;12:407–413. doi:10.2147/VHRM. S105921.
23. Oliveira-Filho AD, Barreto-Filho JA, Neves SJ, Lyra Junior DP. Association Between The 8-item Morisky Medication Adherence Scale (MMAS-8) and Blood Pressure Control. Arq Bras Cardiol. 2012;99(1):649–658. doi:10.1590/s0066782x2012005000053.
24. Akgül C. Hipertansiyon Hastalarında Antihipertansif Uyumun Değerlendirilmesi. Yayınlanmamış Tıpta Uzmanlık Tezi, İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, İstanbul, Türkiye. 2008.
25. Hashmi SK, Afridi MB, Abbas K, Sajwani RA, Saleheen D, Frossard PM, et al. Factors Associated With Adherence to Antihypertensive Treatment in Pakistan. PLoS One. 2007;2(3):280. doi:10.1371/journal.pone.0000280.
26. Özbayram A. Yeni Hipertansiyon Tanısı Almış Hastalarda Tedavi Uyumu ve Etkileyen Faktörler. Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü; 2006.
27. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of Compliance With Antihypertensive Therapy in a High-Risk Medicaid Population. Journal of the National Medical Association. 2009;101(1):34-39. doi:10.1016/s00279684(15)30808-7.